Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients

International Urology and Nephrology

Volumn 46, Issue 12, 2014, Pages 2409-2414

  Ulu, Sena Memnune ^a   Yuksel, Seref ^a   Altuntaş, Atila ^b   Kacar, Emre ^a   Ahsen, Ahmet ^a   Altug, Abdullah ^a   Celik, Sefa ^a   Sezer, M Tugrul ^b  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Continuous ambulatory peritoneal dialysis; Inflammation; Oxidative stress

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; HEPCIDIN;

ADOLESCENT; ADULT; AGED; ARTERIAL STIFFNESS; BLOOD; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; FIBROBLAST GROWTH FACTORS; HEPCIDINS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84937541005     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0753-7     Document Type: Article

References (43)

1. Sidhu MS, Dellsperger KC (2010) Cardiovascular problems in dialysis patients: impact on survival. Adv Perit Dial 26:47–52
2. Wang AY (2007) Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int 27(Suppl 2):S223–S227
3. Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434–2439
4. Wang MC, Tsai WC, Chen JY, Huang JJ (2005) Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 45:494–501
5. van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Stehouwer CD (1998) Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13:1782–1786
6. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H (2002) Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17:1713–1724
7. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23:586–593
8. Wang AY-M, Woo J, Lam CW-K et al (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20:1676–1685
9. Covic A, Goldsmith DA, Florea L et al (2004) The influence of dialysis modality on arterial stiffness, pulse wave reflections, and vasomotor tone. Perit Dial Int 34:365–372
10. Sigrist M, Bungay P, Taal MW, McIntyre CW (2006) Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21(3):707–714
11. Yilmaz FM, Akay H, Duranay M, Yilmaz G, Oztekin PS, Kosar U, Tekeli N, Altay M, Parpucu H, Yucel D (2007) Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Clin Biochem 40(18):1361–1366
12. Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, Hwang TG, Baik SH, Choi DS, Kim SM, Choi KM (2011) Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf) 75(4):464–469
13. Kuragano T, Shimonaka Y, Kida A et al (2010) Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Am J Nephrol 31:534–540
14. Ertek S, Torun AN, Ates K (2010) The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients. Int Urol Nephrol 42(1):211–218
15. Eleftheriadis T, Pissas G, Remoundou M et al (2014) Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin. Int Urol Nephrol 46(1):161–167
16. Himmelfarb J, Hakim RM (2003) Oxidative stress in uremia. Curr Opin Nephrol Hypertens 12(6):593–598
17. Stenvinkel P (2006) Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 11(1):36–41
18. Gusbeth-Tatomir P, Covic A (2007) Causes and consequences of increased arterial Stiffness in chronic kidney disease patients. Kidney Blood Press Res 30(2):97–107
19. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B (2003) Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol 35(3):393–397
20. Van Biesen W, Verbeke F, Vanholder R (2007) Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant 22(1):53–58
21. Puchades MJ, Saez G, Muñoz MC, Gonzalez M, Torregrosa I, Juan I, Miguel A (2013) Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 80(9):177–186
22. Boudouris G, Verginadis II, Simos YV, Zouridakis A, Ragos V, Karkabounas SCH, Evangelou AM (2013) Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation. Int Urol Nephrol 45(4):1137–1144
23. Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM, Cicekler H, Anil M, Ozbek O, Selcuk NY, Yeksan M, Turk S (2012) The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail 34(10):1229–1237
24. Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, Yahiro M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T (2011) Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant 26(8):2663–2667
25. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111
26. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285
27. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37(2):112–119
28. Zhe XW, Tian XK, Chen W, Guo LJ, Gu Y, Chen HM, Tang LJ, Wang T (2008) Association between arterial stiffness and peritoneal fluid kinetics. Am J Nephrol 28(1):128–132
29. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH (2010) Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant 25(12):4041–4048
30. Szeto CC, Kwan BC, Chow KM, Leung CB, Law MC, Li PK (2012) Prognostic value of arterial pulse wave velocity in peritoneal dialysis patients. Am J Nephrol 35(2):127–133
31. Coretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39:257–265
32. Ganesh SK, Hulbert-Shearon T, Port FK et al (2003) Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14:415–424
33. London GM, Marchais SJ, Safar ME et al (1990) Aortic and large artery compliance in end-stage renal disease. Kidney Int 37:137–142
34. Stróżecki P, Donderski R, Grajewska M et al (2010) Factors associated with increased pulse wave velocity in peritoneal dialysis patients. Cent Eur J Med 5:381–386
35. Ueno H, Koyama H, Tanaka S, Fukumoto S, Shinohara K, Shoji T et al (2008) Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 57:1452–1457
36. Paiva H, Kahonen M, Lehtimaki T, Raitakari OT, Jula A, Viikari J et al (2008) Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the Cardiovascular Risk in Young Finns Study. Am J Hypertens 21:873–878
37. Stompor T, Rajzer M, Kawecka-Jaszcz K, Dembinska-Kiec A, Janda K, Wojcik K et al (2005) Renal transplantation ameliorates the progression of arterial stiffness in patients treated with peritoneal dialysis. Perit Dial Int 25:492–496
38. Xu Y, Ding XQ, Zou JZ, Liu ZH, Jiang SH, Chen YM (2011) Serum hepcidin in haemodialysis patients: associations with iron status and Microinflammation. J Int Med Res 39(5):1961–1967
39. Malyszko J, Malyszko JS, Pawlak K, Drozdowska-Rams L, Brzosko S, Mysliwiec M (2008) Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients. Perit Dial Int 28(4):418–421
40. Shoskes DA, Shahed AR, Kim S, Gritsch HA, Danovitch G, Wilkinson A (2001) Oxidant stress and antioxidant capacity in urine of renal transplant recipients predict early graft function. Transplant Proc 33(1–2):984
41. Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL (2011) Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 44(4):275–280
42. Guo CH, Wang CL, Chen PC, Yang TC (2011) Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int 31(5):583–591
43. Malgorzewicz S, Lichodziejewska-Niemierko M, Lizakowski S, Liberek T, Lysiak-Szydlowska W, Rutkowski B (2010) Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients. Clin Nephrol 73(3):210–215